Regarding genetic testing, in a study of 487 individuals with non‐ischemic cardiomyopathy, pathogenic gene variants were identified in 37% of patients, and the patients with LMNA, a nuclear membrane lining protein, had a significantly higher risk of SCD and fatal arrhythmias.46 The gene discussed is LMNA; the disease is ischemic cardiomyopathy.